Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2
Recruiting1
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04967989Phase 3Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Glaucoma and Ocular Hypertension
PrincipalinvestigatorStart date: 2021-09-07
NCT02687815Phase 2Terminated
Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)
Asthma
PrincipalinvestigatorStart date: 2016-02-22
NCT01831739Completed
Genomic Research in Sarcoidosis
Sarcoidosis
Principalinvestigator
NCT01832220Completed
Genomic Research in Alpha-1 Antitrypsin Deficiency
AATDAlpha 1 Antitrypsin Deficiency
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Becich, MD, PhD

University of Pittsburgh

Moderately Similar
2 trials

Shared therapeutic areas:

AATDalpha 1-Antitrypsin DeficiencySarcoidosis

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)University of Pittsburgh
Collaborated on 2 trials
Similarity Score38%

Naftali Kaminski, MD

Yale University

Moderately Similar
2 trials

Shared therapeutic areas:

AATDalpha 1-Antitrypsin DeficiencySarcoidosis

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)University of Pittsburgh
Collaborated on 2 trials
Similarity Score38%

Goundappa K Balasubramani, PhD

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

Glaucoma and Ocular Hypertension

Worked with same sponsors:

National Eye Institute (NEI)University of Pittsburgh+1 more
Collaborated on 1 trial
Similarity Score14%

Tony Realini, MD, MPH

West Virginia University

Related
1 trials

Shared therapeutic areas:

Glaucoma and Ocular Hypertension

Worked with same sponsors:

National Eye Institute (NEI)University of Pittsburgh+1 more
Collaborated on 1 trial
Similarity Score14%

Juan C. Celedón, MD, DrPH

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

Asthma

Worked with same sponsors:

Juan Celedon, MDNational Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

Joel Moss, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
14 trials

Shared therapeutic areas:

AsthmaSarcoidosis

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score12%

Nikolaos Harokopos, MD

General hospital of Pyrgos, Peloponnese, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score6%

Anastasios Palamidas, MD

Sotiria Pulmonary Hospital of Athens

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score6%

Anna Gavriilidou, MD

Papageorgiou hospital of Thessaloniki, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score6%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Asthma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04967989Phase 3PrincipalInvestigator

Clarifying the Optimal Application of SLT Therapy Trial

Glaucoma and Ocular Hypertension
Recruiting
NCT02687815Phase 2PrincipalInvestigator

Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)

Asthma
Terminated
NCT01831739PrincipalInvestigator

Genomic Research in Sarcoidosis

Sarcoidosis
Completed
NCT01832220PrincipalInvestigator

Genomic Research in Alpha-1 Antitrypsin Deficiency

AATDAlpha 1 Antitrypsin Deficiency
Completed

All 4 trials loaded